Susceptibility to lethal cerebral malaria is regulated by epistatic interaction between chromosome 4 (Berr6) and chromosome 1 (Berr7) loci in mice

Genes and Immunity

Volumn 14, Issue 4, 2013, Pages 249-257

  Torre, S ^a   Van Bruggen, R ^a   Kennedy, J M ^a   Berghout, J ^a   Bongfen, S E ^a   Langat, P ^a   Lathrop, M ^a   Vidal, S M ^a   Gros, P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

cerebral malaria; complex traits; epistasis; mouse genetics; quantitative trait locus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CHROMOSOME 1; CHROMOSOME 4; CONTROLLED STUDY; GENE INTERACTION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HAPLOTYPE MAP; HEREDITY; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HOMOZYGOTE; INHERITANCE; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL TIME;

ANIMALS; CHROMOSOMES, MAMMALIAN; DISEASE RESISTANCE; EPISTASIS, GENETIC; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; QUANTITATIVE TRAIT LOCI;

MUS; PLASMODIUM BERGHEI; PLASMODIUM PARASITES;

EID: 84878914996     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.16     Document Type: Article

References (50)

1. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77: 171-192. (Pubitemid 41022702)
2. Longley R, Smith C, Fortin A, Berghout J, McMorran B, Burgio G et al. Host resistance to malaria: using mouse models to explore the host response. Mamm Genome 2011; 22: 32-42.
3. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004; 104: 3364-3371. (Pubitemid 39507160)
4. Friedman MJ. Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci USA 1978; 75: 1994-1997. (Pubitemid 8335470)
5. Flint J, Hill AV, Bowden DK, Oppenheimer SJ, Sill PR, Serjeantson SW et al. High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature 1986; 321: 744-750. (Pubitemid 16077898)
6. Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TE, Newbold CI et al. High incidence of malaria in alpha-thalassaemic children. Nature 1996; 383: 522-525. (Pubitemid 26346177)
7. Foo LC, Rekhraj V, Chiang GL, Mak JW. Ovalocytosis protects against severe malaria parasitemia in the Malayan aborigines. Am J Trop Med Hyg 1992; 47: 271-275.
8. Genton B. Ovalocytosis and cerebral malaria. Nature 1995; 378: 564-565.
9. Allen SJ, O'Donnell A, Alexander ND, Mgone CS, Peto TE, Clegg JB et al. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am J Trop Med Hyg 1999; 60: 1056-1060. (Pubitemid 29296237)
10. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S et al. Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-249.
11. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 2001; 293: 455-462. (Pubitemid 32679066)
12. Aitman TJ, Cooper LD, Norsworthy PJ, Wahid FN, Gray JK, Curtis BR et al. Malaria susceptibility and CD36 mutation. Nature 2000; 405: 1015-1016. (Pubitemid 30447776)
13. Omi K, Ohashi J, Patarapotikul J, Hananantachai H, Naka I, Looareesuwan S et al. CD36 polymorphism is associated with protection from cerebral malaria. Am J Hum Genet 2003; 72: 364-374. (Pubitemid 36194245)
14. Ayi K, Min-Oo G, Serghides L, Crockett M, Kirby-Allen M, Quirt I et al. Pyruvate kinase deficiency and malaria. N Engl J Med 2008; 358: 1805-1810. (Pubitemid 351581192)
15. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600. (Pubitemid 21912384)
16. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510.
17. Bongfen SE, Laroque A, Berghout J, Gros P. Genetic and genomic analyses of hostpathogen interactions in malaria. Trends Parasitol 2009; 25: 417-422.
18. Verra F, Mangano VD, Modiano D. Genetics of susceptibility to Plasmodium falciparum: from classical malaria resistance genes towards genome-wide association studies. Parasite Immunol 2009; 31: 234-253.
19. Hunt NH, Golenser J, Chan-Ling T, Parekh S, Rae C, Potter S et al. Immunopathogenesis of cerebral malaria. Int J Parasitol 2006; 36: 569-582. (Pubitemid 43674512)
20. Fortin A, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria in mice. Genes Immun 2002; 3: 177-186. (Pubitemid 38961129)
21. Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature 2002; 415: 673-679. (Pubitemid 34136400)
22. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ. Plasmodium falciparuminfected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood 2009; 114: 4243-4252.
23. Newton CR, Hien TT, White N. Cerebral malaria. J Neurol Neurosurg Psychiatr 2000; 69: 433-441.
24. Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT et al. Evidence of bloodbrain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 1999; 25: 331-340. (Pubitemid 29392713)
25. Mishra SK. Newton CRJC. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 2009; 5: 189-198.
26. Lou J, Lucas R, Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev 2001; 14: 810-820table of contents. (Pubitemid 32979632)
27. Hafalla JCR, Claser C, Couper KN, Grau GE, Re nia L, de Souza JB et al. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to plasmodium-induced acute immune pathology. PLoS Pathog 2012; 8: e1002504.
28. Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Rachid MA, Soriani FM, Sousa LP et al. Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am J Pathol 2012; 180: 246-255.
29. de Souza JB, Riley EM. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect 2002; 4: 291-300. (Pubitemid 34293634)
30. Senaldi G, Vesin C, Chang R, Grau GE, Piguet PF. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun 1994; 62: 1144-1149. (Pubitemid 24110802)
31. Nagayasu E, Nagakura K, Akaki M, Tamiya G, Makino S, Nakano Y et al. Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria. Infect Immun 2002; 70: 512-516. (Pubitemid 34083808)
32. Bagot S, Campino S, Penha-Goncalves C, Pied S, Cazenave P-A, Holmberg D. Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc Natl Acad Sci USA 2002; 99: 9919-9923. (Pubitemid 34831148)
33. Campino S, Bagot S, Bergman M-L, Almeida P, Sepu lveda N, Pied S et al. Genetic control of parasite clearance leads to resistance to Plasmodium berghei ANKA infection and confers immunity. Genes Immun 2005; 6: 416-421. (Pubitemid 43090517)
34. Ohno T, Nishimura M. Detection of a new cerebral malaria susceptibility locus, using CBA mice. Immunogenetics 2004; 56: 675-678. (Pubitemid 40100801)
35. Berghout J, Min-Oo G, Tam M, Gauthier S, Stevenson MM, Gros P. Identification of a novel cerebral malaria susceptibility locus (Berr5) on mouse chromosome 19. Genes Immun 2010; 11: 310-318.
36. Bongfen SE, Rodrigue-Gervais I-G, Berghout J, Torre S, Cingolani P, Wiltshire SA et al. An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malaria. PLoS One 2012; 7: e31012.
37. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003; 24: 491-499. (Pubitemid 37088152)
38. Amani V, Vigario AM, Belnoue E. Involvement of IFN-g receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol 2000; 30: 1646-1655. (Pubitemid 30342807)
39. Lucas R, Juillard P, Decoster E. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol 2005; 27: 1719-1725.
40. Senaldi G, Shaklee CL, Guo J, Martin L, Boone T, Mak TW et al. Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1. J Immunol 1999; 163: 6820-6826.
41. Miyazaki T, Ono M, Qu W-M, Zhang M-C, Mori S, Nakatsuru S et al. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Eur J Immunol 2005; 35: 1510-1520. (Pubitemid 40691432)
42. Weis JJ, McCracken BA, Ma Y, Fairbairn D, Roper RJ, Morrison TB et al. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol 1999; 162: 948-956. (Pubitemid 29035420)
43. Jackson AU, Galecki AT, Burke DT, Miller RA. Genetic polymorphisms in mouse genes regulating age-sensitive and age-stable T cell subsets. Genes Immun 2003; 4: 30-39. (Pubitemid 38967572)
44. Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994; 1: 219-229.
45. Loh C, Pau E, Lajoie G, Li TT, Baglaenko Y, Cheung Y-H et al. Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice. J Immunol 2011; 186: 5845-5853.
46. Arakura F, Hida S, Ichikawa E, Yajima C, Nakajima S, Saida T et al. Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFNgamma expression influences the pathogenesis of a murine psoriasis-like skin disease. J Immunol 2007; 179: 3249-3257.
47. Bullard DC, Scharffetter-Kochanek K, McArthur MJ, Chosay JG, McBride ME, Montgomery CA et al. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc Natl Acad Sci USA 1996; 93: 2116-2121. (Pubitemid 26079890)
48. Barlow SC, Collins RG, Ball NJ. Psoriasiform dermatitis susceptibility in Itgb2(tm1Bay) PL/J mice requires low-level CD18 expression and at least two additional loci for progression to severe disease. Am J Pathol 2003; 163: 197-202. (Pubitemid 36759604)
49. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002; 11: 661-667. (Pubitemid 34285137)
50. Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J et al. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 2003; 72: 1560-1564. (Pubitemid 36628395)